In a strategic move to propel healthcare innovation in India, Takeda Pharmaceuticals has entered a three-year Memorandum of Understanding (MoU) with India’s Biotechnology Industry Research Assistance Council (BIRAC). The collaboration, witnessed by Dr. Jitendra Singh, Union Minister of State for Science & Technology, aims to foster and guide healthcare innovators from inception to market entry.

Sanjay Patel, Global Head of Data Digital and Technology Innovation Capability Solutions at Takeda Pharmaceuticals, highlighted India's vast potential in healthcare and emphasized the ability of local startups to revolutionize the global healthcare landscape. Serina Fischer, General Manager of Takeda Biopharmaceuticals India, underlined the organization's alignment with India’s healthcare objectives, envisioning this partnership as a blueprint for public-private collaborations driving healthcare advancement.

Ruchi Sogarwal, Head of Corporate Affairs at Takeda Biopharmaceuticals India, emphasized the pivotal role of government-industry-academia alliances in nurturing healthcare innovations. The alliance seeks to bolster competitiveness and translate bioscience advancements into a robust bioeconomy.

Unveiled at Global Bio-India 2023, an event hosted by India’s Department of Biotechnology and BIRAC, this collaboration brings together international and local biotech stakeholders. It marks a significant stride in advancing India’s healthcare innovation ecosystem, showcasing a concerted effort to bolster the nation’s healthcare landscape through strategic partnerships and collaborative initiatives.